Literature DB >> 11040241

Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

D M Lloyd-Jones1, J C Evans, M G Larson, C J O'Donnell, E J Roccella, D Levy.   

Abstract

Data from the Third National Health and Nutrition Examination Survey, phase 2 (1991 to 1994), indicate that among hypertensive individuals in the United States, 53.6% are treated and only 27.4% are controlled to goal levels. We sought to determine whether poor hypertension control is due to lack of systolic or diastolic blood pressure control, or both. We studied Framingham Heart Study participants examined between 1990 and 1995 and determined rates of control to systolic goal (<140 mm Hg), diastolic goal (<90 mm Hg), or both (systolic <140 and diastolic <90 mm Hg). Of 1959 hypertensive subjects (mean age 66 years, 54% women), 32.7% were controlled to systolic goal, 82.9% were controlled to diastolic goal, and only 29.0% were controlled to both. Among the 1189 subjects who were receiving antihypertensive therapy (60.7% of all hypertensive subjects), 49.0% were controlled to systolic goal, 89.7% were controlled to diastolic goal, and only 47.8% were controlled to both. Thus, poor systolic blood pressure control was overwhelmingly responsible for poor rates of overall control to goal. Covariates associated with lack of systolic control in treated subjects included older age (OR for age 61 to 75 years, 2.43, 95% CI 1.79 to 3.29; OR for age >75 years, 4.34, 95% CI 3.10 to 6.09), left ventricular hypertrophy (OR 1.63, 95% CI 1.04 to 2.54), and obesity (OR for body mass index >/=30 versus <25 kg/m(2), 1.49, 95% CI 1.08 to 2.06). In this community-based sample of middle-aged and older subjects, overall rates of hypertension control were remarkably similar to those in the Third National Health and Nutrition Examination Survey. Poor blood pressure control was overwhelmingly due to lack of systolic control, even among treated subjects. Therefore, clinicians and policymakers should place greater emphasis on the achievement of goal systolic levels in all hypertensive patients, especially those who are older or obese or have target organ damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040241     DOI: 10.1161/01.hyp.36.4.594

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  110 in total

1.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

Review 2.  Detection and treatment of resistant hypertension.

Authors:  Julian Segura; Alejandro de la Sierra; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

Review 3.  Management of hypertension in overweight and obese patients: a practical guide for clinicians.

Authors:  Francesco Dentali; Arya M Sharma; James D Douketis
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

4.  Facts and principles learned at the 31st Annual Williamsburg Conference on Heart Disease.

Authors:  Mark A Peterman; Hassan Farooq; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-04

5.  Facts and principles learned at the 32nd annual Williamsburg Conference on Heart Disease.

Authors:  William Clifford Roberts; Hassan Farooq
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

Review 6.  Prevalence and implications of uncontrolled systolic hypertension.

Authors:  William B Kannel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.

Authors:  Hiroyuki Kobori; A Brent Alper; Rajesh Shenava; Akemi Katsurada; Toshie Saito; Naro Ohashi; Maki Urushihara; Kayoko Miyata; Ryousuke Satou; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

8.  Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Authors:  Tanja Dudenbostel; Lama Ghazi; Mingchun Liu; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

9.  The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention.

Authors:  Jan N. Basile
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

10.  Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.

Authors:  Carlos J Rodriguez; Katrina Swett; Sunil K Agarwal; Aaron R Folsom; Ervin R Fox; Laura R Loehr; Hanyu Ni; Wayne D Rosamond; Patricia P Chang
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.